BioSpace - Takeda Pharmaceuticals North America, Inc. News, Search Jobs, Events

BioSpace Login

Enter your BioSpace account email address and password to log in now.

Email Address

Password

Keep me logged in

Close Window

Forgot Your Password? | Privacy Statement

NEW MEMBER SIGN UP

Display Name

Email Address

Password

Password again

Zip

Country

Close Window

Privacy Statement

BioSpace.com

Biotech and Pharmaceutical
News & Jobs

Search the Site

Community Login

What is this?

Employers
Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile

Takeda

Takeda Pharmaceuticals North America, Inc.
One Takeda Parkway

Deerfield Illinois 60015 U.S.A.
Phone: 224-554-6500 Fax: n/a

View Clinical Trials from BioPharm Insight

Takeda Pharmaceuticals North America, Inc. is dedicated to serving patients by providing innovative products that improve their lives with better healthcare. It is a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Japan's largest pharmaceutical company and one with a more than 227-year heritage. Takeda's US clinical development activities are conducted via Takeda Global Research & Development Center, Inc.

Takeda focuses on a variety of therapeutic areas including diabetes, cardiovascular disease, central nervous system disorders, gastroenterology, bone and joint disorders, chronic kidney disease, gynecological disorders, and infectious disease. With a promising pipeline and successful products in multiple therapeutic areas, the company is one of the fastest growing pharmaceutical companies in the United States.

Our mission is simple and compelling: we are dedicated to serving patients by providing innovative products that improve their lives with better healthcare. Our commitment to patients, employees, partners, and the larger community gives us the purpose to build on the tremendous success we enjoy as an emerging global leader in the pharmaceutical industry

For more information, please visit:
http://www.tpna.com/

Key Statistics

Email:
Ownership:
Web Site: Takeda Pharmaceuticals North America, Inc.
Employees: 5,500+
Symbol:

Industry
Biotechnology
Pharmaceutical

Collaborations
SmithKline Beecham
Human Genome Sciences, Inc. Human Gene Consortium Partners

Company News

Takeda Pharmaceuticals North America, Inc. (JOBS) Establishes Takeda Pharmaceuticals Mexico, S.A. de C.V. Expanding Presence in North America 11/3/2009 8:22:04 AM More...

Takeda Pharmaceuticals North America, Inc.'s Uloric (Febuxostat) Demonstrated Efficacy For Management Of Hyperuricemia In Patients With Gout, University of Chicago Study 10/19/2009 11:33:57 AM More...

Takeda Pharmaceuticals North America, Inc.: ULORIC(R) Demonstrated Efficacy for Management of Hyperuricemia in Patients with Gout 10/19/2009 9:13:53 AM More...

Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals North America, Inc. (JOBS) Bowel Drug Lubiprostone Produces Mixed Results In Studies 7/22/2009 8:24:28 AM More...

Sucampo Pharmaceuticals, Inc. Board of Directors Issues Statement Regarding Sales Performance by Takeda Pharmaceuticals North America, Inc. for AMITIZA 5/29/2009 9:13:57 AM More...

Takeda Pharmaceuticals North America, Inc. Release: KAPIDEX(TM) (dexlansoprazole) Delayed Release Capsules Now Available for the Treatment of GERD 2/24/2009 9:52:49 AM More...

No Heart Risk Seen with Takeda Pharmaceuticals North America, Inc. Gout Drug Says U.S. FDA 11/21/2008 7:43:10 AM More...

Takeda Pharmaceuticals North America, Inc.'s Investigational PPI TAK-390MR Demonstrated Higher Healing Rates Compared to Lansoprazole as the Severity of Erosive Esophagitis Grade Increased, a New Integrated Analysis Showed TAK-390MR Data Presented at the American College of Gastroenterology Annual Meeting 10/6/2008 10:46:57 AM More...

Takeda Pharmaceuticals North America, Inc. AMITIZA(R) (lubiprostone) 8 mcg Now Available to Treat Irritable Bowel Syndrome with Constipation in Adult Women 5/27/2008 10:45:20 AM More...

FDA Approves AMITIZA(R) for the Treatment of Irritable Bowel Syndrome with Constipation in Adult Women; Medicine Marketed by Takeda Pharmaceutical Co. Ltd. (TKDG.DE) and Its Developer, Sucampo Pharmaceuticals, Inc. 4/30/2008 6:57:06 AM More...

1